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Abstract
Background: The importance of depression as a complication of HIV infection is increasingly
understood, and people living in rural areas are at increased risk for depression. However, it is not
known whether living in rural areas amplifies the risk of depression in patients with HIV.
Methods: We compared the prevalence of depression between rural and metropolitan HIV
patients seen at the Dartmouth-Hitchcock HIV Program in a retrospective cohort study. Using the
validated Rural-Urban Commuting Area Score, we categorized patients as living in small town/rural
areas, micropolitan or metropolitan towns. Then, using a multivariate logistic regression model to
adjust for demographic factors that differed between rural and metropolitan patients, we estimated
the impact of living in rural areas on the odds of depression.
Results: Among 646 patients with HIV (185 small town/rural, 145 micropolitan, 316
metropolitan), rural patients were older, white, male, and men who have sex with men (ANOVA,
F-statistic < 0.05). The prevalence of depression was highest in rural patients (59.5 vs. 51.7 vs.
41.2%, F statistic < 0.001), particularly rural patients on antiretroviral therapy (72.4 vs. 53.5 vs.
38.2%, F-statistic < 0.001. A multivariate logistic regression model showed that the odds of
depression in rural patients with HIV were 1.34 (P < 0.001).
Conclusion: HIV-infected patients living in rural areas, particularly those on antiretroviral therapy,
are highly vulnerable to depression.
Background
Since its identification in 1981 [1], HIV infection in the
United States has spread from coastal cities to inland rural
towns [2-4]. HIV care in rural areas is inferior to HIV care
in urban areas: rural patients cite greater obstacles to care,
see less experienced HIV providers, and are less likely to
receive antiretroviral treatment or prophylaxis against
Pneumocystis jiroveci pneumonia (PCP) than their urban
counterparts [5,6]. Accordingly, we recently found that
rural patients with HIV have higher mortality rates [7].
Depression is the most common neuropsychiatric com-
plication of HIV disease [8]. The point prevalence of
major depression in HIV infected individuals is 4–10%,
with lifetime prevalence estimated between 22–45% [8].
HIV-infected patients with depression experience poorer
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physical and social well-being and greater bodily pain.
Lastly, HIV patients with depression are less adherent to
antiretroviral therapy (ART), and have lower CD4 counts
along with an unfavorable general prognosis [9-14].
Given the increasing prevalence of HIV in rural areas, and
prior data suggesting that rural patients without HIV
infection are at high risk of depression [15], we examined
whether living in rural areas amplifies the risk of depres-
sion in HIV-infected patients from New England.
Methods
Subjects and data acquisition
We conducted a retrospective study of 646 adult HIV
patients seen from 1995–2005 at four federally funded
clinics encompassing the Dartmouth-Hitchcock HIV Pro-
gram. Regardless of their location of residence, patients
received care from the same multidisciplinary HIV team
consisting of physicians, nurses, psychologists, nutrition-
ists and other support staff. We included all patients in
our HIV program in this analysis who were seen in our
clinics more than one time throughout our study period,
with the exception of those with inadequate residency
records. Demographic and clinical characteristics were
assessed using a retrospective medical records review fol-
lowing approval by the Committee for Protection of
Human Subjects at Dartmouth College and in accordance
with the Declaration of Helsinki. We used de-identified
data and therefore were exempted from obtaining
informed consent from our study subjects.
Study endpoints
We assessed the prevalence of the diagnosis of depression
by a physician at any time point according to the medical
records. We did not require that our study population
meet specific diagnostic criteria for depression. To charac-
terize patients' residency, we utilized the Rural-Urban
Commuting Area (RUCA) score, a validated categorical
measure based on population and commuting patterns
[16]. According to standard RUCA guidelines, we used
three categories: small town/rural areas (population <
10,000), micropolitan (population 10,000–49,999), and
metropolitan (population > 50,000). In subset analyses,
we combined the two non-metropolitan RUCA categori-
zations, designating subjects in this combined group as
'rural.'
Additional variables
To assess the impact of other clinical variables on the rela-
tionship between rurality and depression, we also
abstracted the following from the medical record: age in
2007, race, sex, CD4 counts, ART history, and measures
for driving time and distance. We categorized subjects
based on CD4 count at their first and last data point
according to two thresholds: below 200 cells/mm3, in
which patients were designated as having AIDS, and
below 350 cells/mm3, which signified eligibility to start
ART during the evaluation period. Patients were classified
as having AIDS if, at any time in their medical record, they
met the 1993 CDC AIDS Surveillance case definitions of
AIDS [17]. We also recorded whether they were ever diag-
nosed with an opportunistic infection during the eleven
year study period. Lastly, we used Mapquest.com to deter-
mine the distance and time between the zip codes of the
patient's home location and their preferred clinic loca-
tion.
Statistical Analysis
When comparing depression between the three categories
of the RUCA score, we used a one-way analysis of variance
(ANOVA) model. When conducting univariate compari-
sons between two groups, we used a t test. Variables that
were significantly different between groups in univariate
analyses were incorporated a priori into a multivariate
logistic regression analysis. The likelihood ratio test was
used to detect interaction between the terms used in mul-
tivariate analyses. For all analyses, we considered P values
< 0.05, and ANOVA F-statistic values < 0.05, to be statisti-
cally significant. All statistical analyses were performed
using STATA 9.0 (College Station, TX).
Results
Study Population
Table 1 highlights demographic characteristics and HIV
information of patients in the Dartmouth-Hitchcock HIV
Program from 1995–2005 according to RUCA category of
residency. Patients living in rural areas were older and
more likely to be male, white, and men who have sex with
men.
Depression in rural patients with HIV: prevalence and risk 
factors
We found that the prevalence of depression was highest in
patients living in small town/rural areas, and in micropo-
litan towns, compared to metropolitan areas, respectively
(59.5 vs. 51.7 vs. 41.0%, F statistic < 0.001). The major
risk factors for depression were white race and intrave-
nous drug use (Table 2). Figure 1 indicates that the preva-
lence of depression increased over time in all patients; this
trend was most pronounced in patients living in small
town/rural areas.
Modifiers of Depression Prevalence
We investigated whether the prevalence of depression var-
ied as a function of HIV disease progression. Most recent
CD4 counts were similar among patients with and with-
out depression (433.4 vs. 453.5 cells/mm3, P = 0.384).
Similarly, CD4 counts were similar in subjects from small
town/rural areas, micropolitan and metropolitan towns
(455.3 vs. 426.4 vs. 444.0 cells/mm3, F-statistic 0.672).
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Further, we found that the relationship between depres-
sion and rural residency persisted when stratified by CD4
count strata (Table 3). When we grouped patients from
small town/rural areas and micropolitan towns together
and compared them to metropolitan patients, the preva-
lence of depression was greater in rural patients (CD4
counts < 200 cells/mm3, 55.0 vs. 40.0%, P = 0.073; CD4
counts 200–350 cells/mm3, 60.9 vs. 34.8%, P = 0.002;
and, CD4 counts > 350 cells/mm3, 54.4 vs. 43.2%, P =
0.033).
We next explored how ART impacts the relationship
between rural residency and depression. Here, we found
that the prevalence of depression was greater in patients
Table 1: Characteristics of patients in Dartmouth-Hitchcock HIV Program by RUCA categorization (1995–2005)
Small Town/Rural (n = 185) Micropolitan (n = 145) Metropolitan (n = 316) F Statistic by ANOVA
Age, years 43.6 43.0 41.5 0.019
Male, % 79.6 80.3 64.4 < 0.001
Population of town, mean 5,598 14,389 79,168 < 0.001
Race, %
White 94.1 92.4 77.5 < 0.001
Black 5.41 5.52 21.5 < 0.001
Asian 0.0 1.38 0.95 0.324
Risk Factor, %
Heterosexual 24.1 24.8 36.8 0.007
Intravenous drug use 16.5 19.0 17.5 0.857
Men who have sex with men 58.2 60.3 46.4 0.011
Hemophilia 3.2 0.8 0.8 0.113
HIV disease status
CD4 T cell count at diagnosis, cells/
mm3
378.0 321.6 373.9 0.178
CD4 T cell count at last follow-up, 
cells/mm3
455.3 426.4 444.0 0.672
HAART, % 47.0 43.0 40.8 0.533
Opportunistic infections, % 34.1 38.9 22.9 < 0.001
Acquired immunodeficiency syndrome, 
%
61.6 64.6 50.8 0.007
Follow-Up Time, years 10.5 9.30 8.30 < 0.001
Access to Care
MapQuest Travel Time, minutes 60.7 51.7 33.5 < 0.001
MapQuest Travel Distance, miles 47.2 39.9 25.6 < 0.001
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on ART compared to those not on ART (54.6 vs. 39.8%, P
= 0.014). When stratifying our analysis of the relationship
between depression and living in rural areas by antiretro-
viral treatment status, we found that the relationship was
significant only in rural patients on ART (Table 3). Simi-
larly, when grouping patients from small town/rural areas
and micropolitan towns together, we found that the prev-
alence of depression was higher in rural patients on ART
(64.8 vs. 38.3%, P < 0.001) but not in rural patients off
ART (55.9 vs. 46.8%, P = 0.150).
Next, we explored if the prevalence of depression differed
between the four Dartmouth-Hitchcock HIV clinic sites.
Table 4 shows that depression was a more common diag-
nosis in our rural clinics (ANOVA F statistic < 0.001).
Multivariate Models
In a logistic regression model comparing the prevalence of
depression in small town/rural areas, micropolitan, and
metropolitan patients, the unadjusted odds of depression
in rural patients was 1.46 (CI 1.22–1.75, P < 0.001), indi-
cating increasing risk in increasingly rural areas. Adjusting
for age, sex and HIV acquisition risk factor, we found that
the odds of depression in rural patients was 1.34 (CI
1.09–1.65, P < 0.001). Table 5 shows these and additional
logistic regression models, all of which show a significant
relationship between living in rural areas and depression.
Discussion
In the United States today, rural patients with HIV face
greater obstacles to medical care, receive less expert HIV
care, experience reduced access to antiretroviral treatment,
and have higher mortality rates [3,18,19]. We now show
that the prevalence of depression is higher in HIV patients
living in rural areas, particularly those on ART. In fact, we
observed a gradient of increasing depression moving from
metropolitan to micropolitan towns and into small town/
rural areas.
The prevalence of depression we observed in rural patients
with HIV is higher than rates reported in other popula-
tions. Previous studies have cited a prevalence of depres-
sion of 5.2% in the general population [20], 6.1% in rural
populations [15], and a 9.4% in HIV-infected individuals
[20]. While the depression rates in HIV-infected patients
in our study cannot be compared directly to these figures,
the 59.5% prevalence of depression in HIV patients from
small town/rural areas over an 11-year period clearly sug-
gests that these patients are highly vulnerable to this dev-
astating disease.
Further, we found that the prevalence of depression was
highest in rural patients on ART. While this finding may
recapitulate the prior observation that depression is more
common with advanced HIV [21,22], it is also possible
Prevalence of depression based on time since HIV diagnosis based on patient residenceFigur  1
Prevalence of depression based on time since HIV diagnosis based on patient residence. Prevalence of depression 
based on time since HIV diagnosis in patients living in small town/rural areas, micropolitan, and metropolitan areas.
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that the greater vulnerability to depression of rural
patients on ART stems from treatment fatigue. Our find-
ing that depression prevalence remains elevated for rural
HIV patients across multiple CD4 strata supports this pos-
sibility.
HIV-infected rural patients are demographically distinct
from HIV patients living in metropolitan areas. Adjusting
for these factors in the multivariate model did not impact
the clear relationship between living in rural areas and
depression. This suggests that demographics alone do not
explain the higher depression prevalence in rural HIV
patients in New England. Additionally, it newly defines
risk factors for depression in this high risk cohort.
We were unable to determine why the prevalence of
depression is higher in rural HIV patients. However, we
hypothesize that inadequate social support is a major con-
tributor. Two findings support this hypothesis: inade-
quate social support is linked to higher risk of depression
in patients without HIV [23,24], and there are fewer social
support resources for HIV care in rural areas [6,25]. Since
patients with HIV are vulnerable to unstable employment
[26], one source for poor social support is limited access
to insurance benefits and associated community
resources. Furthermore, our clinical experience suggests
that support services for HIV care are weak, especially in
the small town/rural areas where the prevalence of depres-
sion in our patients was the highest. Similarly, because
Table 2: Depression risk factors for all individuals in Dartmouth-Hitchcock HIV Program (1995–2005)
Depression (n = 314) No Depression (n = 331) P value by t test
Age, years 42.9 42.0 0.189
Male, % 74.4 70.6 0.312
Race, %
White 90.1 81.2 0.001
Black 9.2 17.2 0.003
Asian 0.3 1.2 0.198
HIV risk factor, %
Heterosexual 24.3 36.6 0.002
Intravenous drug use 21.7 13.2 0.009
Men who have sex with men 56.9 49.1 0.068
Hemophilia 0.4 2.7 0.028
HIV disease status
Acquired immunodeficiency syndrome, % 54.1 48.0 0.121
Opportunistic infection, % 29.5 29.8 0.934
CD4 T cell count at last follow-up, cells/mm3 433.4 453.5 0.384
Follow-Up Time, years 10.2 8.12 < 0.001
Access to Care
MapQuest Travel Time, minutes 43.3 47.3 0.206
MapQuest Travel Distance, miles 33.8 36.2 0.358
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poor social support is known to predict depression in
patients on ART [27], we suspect that inadequate local
social support for HIV care may contribute to the
extremely high prevalence of depression in rural HIV
patients on ART. This is a critical point, because depres-
sion undermines ART adherence and is correlated with
poorer HIV prognosis [28-30]. Stigma is another major
likely contributor to the increasing prevalence of depres-
sion in rural areas. Others have shown that rural patients
are more likely to encounter AIDS-related stigma [26],
and we posit this may contribute to the great vulnerability
to depression we observed in our rural patients.
Our study has important methodological limitations that
should be acknowledged. First, the diagnosis of depres-
sion in patients in this study was not based on formal cri-
teria; rather, we relied on clinician diagnosis. Thus,
provider variability in diagnosis may impact the defini-
tion of depression in our study population. However,
using this operational definition of depression reflects
real world clinical practice [31], and as such is likely to
capture a real burden of psychiatric disease in our study
population.
Second, we measured the prevalence of the diagnosis of
depression over an eleven year period, not the point prev-
alence of depression. Therefore, our data are not amena-
ble to survival analysis, and thus bias introduced by
differential follow-up between groups is possible. One
potential source for differential follow-up is migration. It
is conceivable that patients from metropolitan areas left
our cohort at a different rate compared to those living in
rural areas; however, adjusting for follow-up time in our
multivariate model did not undermine the significant
relationship between living in rural areas and the preva-
lence of depression.
Furthermore, we did not characterize the severity of
depression or use a rigorous validated screening tool.
Thus, our data cannot capture the dynamic incidence or
variable severity of the disease, and how this might vary
geographically. Lastly, it is possible that individuals in our
cohort acquired the diagnosis of depression prior to their
HIV diagnosis, and as a result, a substantial proportion of
the increased depression prevalence is independent of
HIV disease. Nevertheless, it is clinically important that
the prevalence of depression in rural HIV patients is much
higher than that reported in either rural or HIV popula-
tions studied independently.
Importantly, we identified multiple risk factors for depres-
sion in HIV patients, including white race and intravenous
Table 3: Prevalence of Depression in Rural and Metropolitan Areas Stratified by CD4 Cell Count and Use of Antiretroviral Therapy
Small Town/Rural Areas Micropolitan Metropolitan ANOVA F-Statistic
CD4 count, cells/mm3
< 200 53.3 57.1 40.0 0.191
200–350 74.4 43.3 34.8 < 0.001
> 350 55.9 52.5 43.2 0.033
ART Use
Yes 72.4 53.5 38.2 < 0.001
No 60.0 50.9 46.9 0.211
Table 4: Diagnosis of Depression by Clinic Location
Clinic Location City Population RUCA Categorization Patients with Depression, n (%)
Manchester, NH 107,006 Metropolitan 99/219 (45.2)
Lebanon, NH 12,688 Micropolitan 164/322 (50.9)
Brattleboro, VT 12,006 Micropolitan 36/45 (80.0)
Nashua, NH 86,605 Metropolitan 15/58 (25.9)
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drug use. However, when controlling for these risk factors
in our multivariate analyses, the strong relationship
between living in rural areas and the prevalence of depres-
sion remained. Therefore, we believe these results are gen-
eralizable despite the demographic differences between
our rural HIV cohort and those seen in other rural areas of
the United States [3,18,32].
We recognize that rurality is a necessarily subjective desig-
nation, but believe that the use of validated RUCA scale
lends credence to our findings [16]. Additionally, the fact
that we demonstrated a gradient of depression moving
from metropolitan cities to micropolitan cities and to
small town/rural areas further supports the idea that liv-
ing in rural areas is an important risk factor for depression
in patients with HIV.
Conclusion
Rural patients with HIV are highly vulnerable to major
depression, especially those from small town/rural areas.
This risk is most pronounced in rural HIV patients on
ART. We believe that poor social supports, HIV-related
stigma, and antiretroviral treatment fatigue all contribute
to the pronounced vulnerability of rural HIV patients to
depression.
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